NeoPharm Investigators Present Results of IL13-PE38QQR Multicenter Phase I Clinical Studies at the World Federation of Neuro-Oncology -- Prolonged Overall Median Patient Survival Observed

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines.